HIV and AIDS Treatments

HOME

HIV and AIDS Main Section

FDA-approved HIV and AIDS Treatments

Link to Experimental Treatments for HIV/AIDS

Protease Inhibitors

Fixed-dose Combinations

non Nucleoside Reverse Transcriptase Inhibitors

Entry Inhibitors (including Fusion Inhibitors)

Nucleoside / Nucleotide Reverse Transcriptase Inhibitors

Integrase Inhibitors

*Top*	Protease Inhibitors
	Agenerase (amprenavir)
	Aptivus (tipranavir)
	Crixivan (indinavir)
	Invirase (saquinavir)
	Kaletra (lopinavir/ritronavir)
	Lexiva (fosamprenavir)
	Norvir (ritonavir)
	Prezista (darunavir)
	Reyataz (atazanavir)
	Viracept (nelfinavir)

*Top*	Nucleoside / Nucleotide Reverse Transcriptase Inhibitors
	Combivir (AZT+ 3TC)
	Epivir (lamivudine; 3TC)
	Emtriva (emtricitabine; FTC)
	Epzicom (abacavir + lamivudine)
	Retrovir (zidovudine; AZT)
	Trizivir (abacavir + zidovudine +lamivudine)
	Truvada��(tenofovir + emtricitabine)
	Videx (didanosine; ddI)
	Viread (tenofovir)
	Zerit (stavudine; d4T)
	Ziagen (abacavir)

*Top*	non Nucleoside Reverse Transcriptase Inhibitors
	Rescriptor (delavirdine)
	Intelence (etravirine)
	Sustiva (efavirenz)
	Viramune (nevirapine)

*Top*	Entry Inhibitors (including Fusion Inhibitors)
	Fuzeon (enfuvirtide)
	Selzentry ( maraviroc)

*Top*	Integrase Inhibitors
	Isentress (raltegravir)

*Top*	Fixed-dose Combinations
	Atripla (efavirenz + emtricitabine + tenofovir)
	Combivir (retrovir + lamivudine)
	Epzicom (abacavir + lamivudine)
	Trizivir (abacavir + zidovudine + lamivudine)
	Truvada (tenofovir + emtricitabine)